Table 1.

Simple obese (OB-G) patients.

Code	Age	Sex	BMI at onset	BMI-SDS	Obeisty subgroup	Total cholesterol	HDL	LDL	TRG	Glycemia 0'	Glycemia 60'	Glycemia 120	Glicated Hb	Total insulin	CRP	Ultrasensitive CRP	HepaticSteatosis	Metformin therapy	Other clinical infos
5D	12.8	F	37.8	3.39	OB-SO-G	184	40	ND	ND	87	199	174	5.6	1364	0.23	2.22	No	No	Systolic hypertension
6D	8.8	F	31.6	3.62	OB-SO-G	180	35	120	ND	99	142	136	4.5	331	0.61	4.93	Yes	No
7D	15.8	M	36.3	3.16	OB-SO-G	ND	ND	ND	ND	96	117	118	ND	727	0.23	ND	ND	No
24D	15.3	F	34.1	2.79	OB-O-G	177	43	110	93	88	92	89	4.87	627	0.23	1.36	Yes	No	Sodium butyrrate
27D	9.8	F	25.2	2.54	OB-O-G	160	70	86	55	95	193	132	5.28	606	0.65	6.25	ND	No
39D	16.3	F	33.4	2.65	OB-O-G	151	40	95	88	89	89	109	5.03	316	0.23	0.79	Yes	No
51D	10.2	M	24.6	2.64	OB-O-G	186	66	104	58	90	136	119	5.36	558	0.23	2.83	No	No
67D	11.1	M	34.3	3.56	OB-SO-G	163	68	97	69	83	104	104	5.04	665	0.67	6.07	No	No	Hepatomegaly
79D	13.8	F	39.8	3.29	OB-SO-G	147	47	92	71	104	183	148	5.32	1166	0.97	9.73	No	Yes
83D	12.3	M	34	3.29	OB-SO-G	128	47	74	65	98	152	130	5.17	244	0.54	5.11	ND	No	Obesity and asma
85D	8.8	M	34.6	4.4	OB-SO-G	130	58	64	114	95	ND	ND	4.56	ND	0.23	1.3	Yes	No
108D	10.9	M	29	3.12	OB-SO-G	117	44	71	39	85	113	118	5.35	302	0.23	1.95	No	No	Severe Obesity, Asma and OSAS
120D	16.7	F	33	2.58	OB-O-G	112	38	71	80	115	191	178	5.4	ND	0.23	1.34	No	No	Pre-diabetes with insulin resistance. OSAS—hypercapnia
125D	17.8	F	35.5	2.9	OB-O-G	130	40	72	50	83	92	107	4.96	488	0.23	0.93	No	Yes	Asma. dicoflor therapy. polycystic ovary syndrome (PCOS)
135D	10.6	M	47	4.33	OB-SO-G	127	47	68	80	84	ND	101	4.95	ND	1.42	14.45	No	No	Niaprazine, aripiprazole and depakin therapy
137D	10.4	M	23	2.26	OB-O-G	165	56	104	55	115	169	189	5.75	601	0.23	2.07	No	No
138D	15.9	M	43.7	3.76	OB-SO-G	182	54	109	99	94	155	135	5.21	804	0.23	1.39	Yes	No	Gallbladder stones
140D	10.6	M	36.2	3.8	OB-SO-G	157	69	79	157	ND	ND	ND	5.43	ND	0.68	6.48	Yes	No
146D	12.5	M	29.2	2.7	OB-O-G	140	52	79	82	84	135	115	5.4	1128	0.48	4.63	ND	No	Essential hypertension under therapy
148D	17.5	F	44.7	3.83	OB-SO-G	157	53	94	74	86	118	127	5.10	552	0.23	3.28	ND	No	Severe obesity
149D	12.8	M	31.4	2.98	OB-O-G	178	64	108	43	93	ND	ND	ND	ND	0.23	0.71	Yes	No
151D	14	M	42.2	3.66	OB-SO-G	109	58	53	42	93	131	137	5.19	289	0.47	4.24	Yes	No	Severe obesity and hepatic steatosis
154D	11.4	M	27.2	2.74	OB-O-G	177	42	122	133	88	140	122	5.4	748	0.23	1.5	Yes	No	Celiac. obesity and steatosis
156D	13.2	M	38	3.46	OB-SO-G	113	53	56	46	87	183	139	5.34	2000	0.83	7.88	Yes	No	insulin resistance (2000). Mental retardation, q21.1 duplication
160D	9.8	F	24.9	2.49	OB-O-G	176	65	97	64	89	187	114	5.02	787	0.23	2.07	ND	No
161D	10.6	F	26	2.48	OB-O-G	172	68	96	50	104	ND	ND	4.74	ND	0.23	0.25	ND	No	Hypertension
162D	12.5	M	39.8	3.65	OB-SO-G	157	38	111	87	85	119	91	5.17	765	0.23	3.33	No	No	Obesity + mild OSAS
168D	11.2	M	50.4	4.24	OB-SO-G	149	46	101	89	94	116	118	4.9	340	1.22	12.3	Yes	No	Severe obesity and hepatic steatosis
170D	12.1	M	37.5	3.57	OB-SO-G	119	61	59	54	102	156	133	4.81	858	0.23	2.8	Yes	No	Severe obesity and RPM. Glucose intollerance. Known chromosome deletion Sigmacillin i.m.therapy
179D	16.2	F	37.9	3.18	OB-SO-G	148	43	104	75	94	119	108	4.26	326	0.23	1.03	ND	No	Depression
180D	5.8	M	26.6	4.94	OB-SO-G	135	41	90	89	104	105	138	5.35	215	1.37	12.38	No	No	Severe obesity and moderate OSAS
184D	16.5	M	43	3.75	OB-SO-G	133	34	88	75	99	134	119	5.5	929	0.9	8.4	Yes	No	Severe obesity and OSAS
186D	9.8	M	29.1	3.45	OB-SO-G	130	33	85	74	87	117	122	5.38	690	0.23	0.75	No	No	Hypertension
195D	14.5	M	27.7	2.25	OB-SO-G	210	39	131	136	97	202	127	4.97	1259	0.23	0.36	Yes	No